HEADER LIPID TRANSPORT 17-APR-09 3H3T TITLE CRYSTAL STRUCTURE OF THE CERT START DOMAIN IN COMPLEX WITH HPA-16 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GOODPASTURE ANTIGEN BINDING PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CERT START DOMAIN (RESIDUES 347-598); COMPND 5 SYNONYM: CDNA FLJ77923, HIGHLY SIMILAR TO HOMO SAPIENS COLLAGEN, TYPE COMPND 6 IV, ALPHA 3 (GOODPASTURE ANTIGEN) BINDING PROTEIN, COL4A3BP, COMPND 7 TRANSCRIPT VARIANT 2, MRNA, COLLAGEN, TYPE IV, ALPHA 3 (GOODPASTURE COMPND 8 ANTIGEN) BINDING PROTEIN, ISOFORM CRA_A; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: DH5ALPHA; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-5X1 (MODIFIED) KEYWDS LIPID TRANSFER PROTEIN, CERT, CERAMIDE TRANSFER, LIPID TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR N.KUDO,S.WAKATSUKI,R.KATO REVDAT 3 01-NOV-23 3H3T 1 REMARK SEQADV REVDAT 2 01-NOV-17 3H3T 1 REMARK REVDAT 1 02-MAR-10 3H3T 0 JRNL AUTH N.KUDO,K.KUMAGAI,R.MATSUBARA,S.KOBAYASHI,K.HANADA, JRNL AUTH 2 S.WAKATSUKI,R.KATO JRNL TITL CRYSTAL STRUCTURES OF THE CERT START DOMAIN WITH INHIBITORS JRNL TITL 2 PROVIDE INSIGHTS INTO THE MECHANISM OF CERAMIDE TRANSFER. JRNL REF J.MOL.BIOL. V. 396 245 2010 JRNL REFN ISSN 0022-2836 JRNL PMID 20036255 JRNL DOI 10.1016/J.JMB.2009.12.029 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0069 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 18577 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 948 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1269 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.11 REMARK 3 BIN R VALUE (WORKING SET) : 0.2480 REMARK 3 BIN FREE R VALUE SET COUNT : 67 REMARK 3 BIN FREE R VALUE : 0.3630 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3776 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 35 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.34000 REMARK 3 B22 (A**2) : 0.31000 REMARK 3 B33 (A**2) : 0.69000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.50000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.675 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.302 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.220 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.304 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.916 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3926 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5334 ; 1.469 ; 1.944 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 468 ; 6.476 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 191 ;33.818 ;24.346 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 649 ;16.320 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;21.106 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 593 ; 0.109 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2986 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2351 ; 0.718 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3840 ; 1.381 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1575 ; 1.957 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1494 ; 3.342 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3H3T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 22-APR-09. REMARK 100 THE DEPOSITION ID IS D_1000052656. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NW12A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9778 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18692 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.0820 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.34000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2E3N REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION, TEMPERATURE 293K, REMARK 280 VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.28400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THERE ARE 2 BIOLOGICAL UNITS IN THE ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 344 REMARK 465 ASN A 345 REMARK 465 SER A 346 REMARK 465 LEU A 347 REMARK 465 HIS A 348 REMARK 465 TRP A 349 REMARK 465 PRO A 350 REMARK 465 THR A 351 REMARK 465 SER A 352 REMARK 465 LEU A 353 REMARK 465 PRO A 354 REMARK 465 SER A 355 REMARK 465 GLY A 356 REMARK 465 ASP A 357 REMARK 465 ALA A 358 REMARK 465 PHE A 359 REMARK 465 SER A 360 REMARK 465 SER A 361 REMARK 465 VAL A 362 REMARK 465 SER B 344 REMARK 465 ASN B 345 REMARK 465 SER B 346 REMARK 465 LEU B 347 REMARK 465 HIS B 348 REMARK 465 TRP B 349 REMARK 465 PRO B 350 REMARK 465 THR B 351 REMARK 465 SER B 352 REMARK 465 LEU B 353 REMARK 465 PRO B 354 REMARK 465 SER B 355 REMARK 465 GLY B 356 REMARK 465 ASP B 357 REMARK 465 ALA B 358 REMARK 465 PHE B 359 REMARK 465 SER B 360 REMARK 465 SER B 361 REMARK 465 VAL B 362 REMARK 465 GLY B 363 REMARK 465 THR B 364 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL B 368 CB CG1 CG2 REMARK 470 GLU B 537 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG1 THR B 493 OD2 ASP B 496 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 364 77.24 -110.34 REMARK 500 ASP A 416 101.74 -13.13 REMARK 500 ALA A 512 78.22 -157.20 REMARK 500 ASN A 516 -54.02 -26.20 REMARK 500 GLU B 398 106.79 -165.79 REMARK 500 ASP B 416 99.16 -15.71 REMARK 500 ALA B 475 -179.47 -173.99 REMARK 500 HIS B 509 132.50 -172.18 REMARK 500 LEU B 514 156.71 -47.13 REMARK 500 PRO B 535 151.33 -28.80 REMARK 500 ARG B 544 7.15 -67.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 16H A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 16H B 600 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2E3M RELATED DB: PDB REMARK 900 THE SAME PROTEIN, IN THE APO-FORM REMARK 900 RELATED ID: 2E3N RELATED DB: PDB REMARK 900 THE SAME PROTEIN, COMPLEXED WITH C6-CERAMIDE REMARK 900 RELATED ID: 2E3O RELATED DB: PDB REMARK 900 THE SAME PROTEIN, COMPLEXED WITH C16-CERAMIDE REMARK 900 RELATED ID: 2E3P RELATED DB: PDB REMARK 900 THE SAME PROTEIN, COMPLEXED WITH C16-CERAMIDE REMARK 900 RELATED ID: 2E3Q RELATED DB: PDB REMARK 900 THE SAME PROTEIN, COMPLEXED WITH C18-CERAMIDE REMARK 900 RELATED ID: 2E3R RELATED DB: PDB REMARK 900 THE SAME PROTEIN, COMPLEXED WITH C18-CERAMIDE REMARK 900 RELATED ID: 2E3S RELATED DB: PDB REMARK 900 THE SAME PROTEIN, CO-CRYSTALLIZED WITH C24-CERAMIDE REMARK 900 RELATED ID: 3H3Q RELATED DB: PDB REMARK 900 RELATED ID: 3H3R RELATED DB: PDB REMARK 900 RELATED ID: 3H3S RELATED DB: PDB DBREF 3H3T A 347 598 UNP A8K7S2 A8K7S2_HUMAN 347 598 DBREF 3H3T B 347 598 UNP A8K7S2 A8K7S2_HUMAN 347 598 SEQADV 3H3T SER A 344 UNP A8K7S2 EXPRESSION TAG SEQADV 3H3T ASN A 345 UNP A8K7S2 EXPRESSION TAG SEQADV 3H3T SER A 346 UNP A8K7S2 EXPRESSION TAG SEQADV 3H3T SER B 344 UNP A8K7S2 EXPRESSION TAG SEQADV 3H3T ASN B 345 UNP A8K7S2 EXPRESSION TAG SEQADV 3H3T SER B 346 UNP A8K7S2 EXPRESSION TAG SEQRES 1 A 255 SER ASN SER LEU HIS TRP PRO THR SER LEU PRO SER GLY SEQRES 2 A 255 ASP ALA PHE SER SER VAL GLY THR HIS ARG PHE VAL GLN SEQRES 3 A 255 LYS VAL GLU GLU MET VAL GLN ASN HIS MET THR TYR SER SEQRES 4 A 255 LEU GLN ASP VAL GLY GLY ASP ALA ASN TRP GLN LEU VAL SEQRES 5 A 255 VAL GLU GLU GLY GLU MET LYS VAL TYR ARG ARG GLU VAL SEQRES 6 A 255 GLU GLU ASN GLY ILE VAL LEU ASP PRO LEU LYS ALA THR SEQRES 7 A 255 HIS ALA VAL LYS GLY VAL THR GLY HIS GLU VAL CYS ASN SEQRES 8 A 255 TYR PHE TRP ASN VAL ASP VAL ARG ASN ASP TRP GLU THR SEQRES 9 A 255 THR ILE GLU ASN PHE HIS VAL VAL GLU THR LEU ALA ASP SEQRES 10 A 255 ASN ALA ILE ILE ILE TYR GLN THR HIS LYS ARG VAL TRP SEQRES 11 A 255 PRO ALA SER GLN ARG ASP VAL LEU TYR LEU SER VAL ILE SEQRES 12 A 255 ARG LYS ILE PRO ALA LEU THR GLU ASN ASP PRO GLU THR SEQRES 13 A 255 TRP ILE VAL CYS ASN PHE SER VAL ASP HIS ASP SER ALA SEQRES 14 A 255 PRO LEU ASN ASN ARG CYS VAL ARG ALA LYS ILE ASN VAL SEQRES 15 A 255 ALA MET ILE CYS GLN THR LEU VAL SER PRO PRO GLU GLY SEQRES 16 A 255 ASN GLN GLU ILE SER ARG ASP ASN ILE LEU CYS LYS ILE SEQRES 17 A 255 THR TYR VAL ALA ASN VAL ASN PRO GLY GLY TRP ALA PRO SEQRES 18 A 255 ALA SER VAL LEU ARG ALA VAL ALA LYS ARG GLU TYR PRO SEQRES 19 A 255 LYS PHE LEU LYS ARG PHE THR SER TYR VAL GLN GLU LYS SEQRES 20 A 255 THR ALA GLY LYS PRO ILE LEU PHE SEQRES 1 B 255 SER ASN SER LEU HIS TRP PRO THR SER LEU PRO SER GLY SEQRES 2 B 255 ASP ALA PHE SER SER VAL GLY THR HIS ARG PHE VAL GLN SEQRES 3 B 255 LYS VAL GLU GLU MET VAL GLN ASN HIS MET THR TYR SER SEQRES 4 B 255 LEU GLN ASP VAL GLY GLY ASP ALA ASN TRP GLN LEU VAL SEQRES 5 B 255 VAL GLU GLU GLY GLU MET LYS VAL TYR ARG ARG GLU VAL SEQRES 6 B 255 GLU GLU ASN GLY ILE VAL LEU ASP PRO LEU LYS ALA THR SEQRES 7 B 255 HIS ALA VAL LYS GLY VAL THR GLY HIS GLU VAL CYS ASN SEQRES 8 B 255 TYR PHE TRP ASN VAL ASP VAL ARG ASN ASP TRP GLU THR SEQRES 9 B 255 THR ILE GLU ASN PHE HIS VAL VAL GLU THR LEU ALA ASP SEQRES 10 B 255 ASN ALA ILE ILE ILE TYR GLN THR HIS LYS ARG VAL TRP SEQRES 11 B 255 PRO ALA SER GLN ARG ASP VAL LEU TYR LEU SER VAL ILE SEQRES 12 B 255 ARG LYS ILE PRO ALA LEU THR GLU ASN ASP PRO GLU THR SEQRES 13 B 255 TRP ILE VAL CYS ASN PHE SER VAL ASP HIS ASP SER ALA SEQRES 14 B 255 PRO LEU ASN ASN ARG CYS VAL ARG ALA LYS ILE ASN VAL SEQRES 15 B 255 ALA MET ILE CYS GLN THR LEU VAL SER PRO PRO GLU GLY SEQRES 16 B 255 ASN GLN GLU ILE SER ARG ASP ASN ILE LEU CYS LYS ILE SEQRES 17 B 255 THR TYR VAL ALA ASN VAL ASN PRO GLY GLY TRP ALA PRO SEQRES 18 B 255 ALA SER VAL LEU ARG ALA VAL ALA LYS ARG GLU TYR PRO SEQRES 19 B 255 LYS PHE LEU LYS ARG PHE THR SER TYR VAL GLN GLU LYS SEQRES 20 B 255 THR ALA GLY LYS PRO ILE LEU PHE HET 16H A 600 30 HET 16H B 600 30 HETNAM 16H N-[(1R,3R)-3-HYDROXY-1-(HYDROXYMETHYL)-3- HETNAM 2 16H PHENYLPROPYL]HEXADECANAMIDE FORMUL 3 16H 2(C26 H45 N O3) FORMUL 5 HOH *35(H2 O) HELIX 1 1 PHE A 367 SER A 382 1 16 HELIX 2 2 THR A 428 ASN A 438 1 11 HELIX 3 3 VAL A 441 GLU A 446 1 6 HELIX 4 4 SER A 543 ASP A 545 5 3 HELIX 5 5 PRO A 564 ALA A 592 1 29 HELIX 6 6 PHE B 367 SER B 382 1 16 HELIX 7 7 THR B 428 ASN B 438 1 11 HELIX 8 8 VAL B 441 GLU B 446 1 6 HELIX 9 9 PRO B 564 ALA B 592 1 29 SHEET 1 A 9 GLN A 393 GLU A 398 0 SHEET 2 A 9 MET A 401 ARG A 405 -1 O VAL A 403 N VAL A 396 SHEET 3 A 9 LEU A 418 LYS A 425 -1 O LYS A 419 N TYR A 404 SHEET 4 A 9 ILE A 547 ASN A 558 -1 O TYR A 553 N ALA A 420 SHEET 5 A 9 LYS A 522 VAL A 533 -1 N ILE A 528 O THR A 552 SHEET 6 A 9 THR A 499 SER A 506 -1 N ASN A 504 O VAL A 525 SHEET 7 A 9 ARG A 478 ILE A 489 -1 N ILE A 489 O THR A 499 SHEET 8 A 9 ALA A 462 HIS A 469 -1 N ILE A 465 O TYR A 482 SHEET 9 A 9 ILE A 449 ALA A 459 -1 N GLU A 450 O THR A 468 SHEET 1 B 8 GLN A 393 GLU A 398 0 SHEET 2 B 8 MET A 401 ARG A 405 -1 O VAL A 403 N VAL A 396 SHEET 3 B 8 LEU A 418 LYS A 425 -1 O LYS A 419 N TYR A 404 SHEET 4 B 8 ILE A 547 ASN A 558 -1 O TYR A 553 N ALA A 420 SHEET 5 B 8 LYS A 522 VAL A 533 -1 N ILE A 528 O THR A 552 SHEET 6 B 8 THR A 499 SER A 506 -1 N ASN A 504 O VAL A 525 SHEET 7 B 8 ARG A 478 ILE A 489 -1 N ILE A 489 O THR A 499 SHEET 8 B 8 VAL A 519 ARG A 520 1 O VAL A 519 N ASP A 479 SHEET 1 C 2 GLU A 409 GLU A 410 0 SHEET 2 C 2 ILE A 413 VAL A 414 -1 O ILE A 413 N GLU A 410 SHEET 1 D 9 GLN B 393 GLU B 398 0 SHEET 2 D 9 MET B 401 ARG B 405 -1 O VAL B 403 N VAL B 396 SHEET 3 D 9 LEU B 418 LYS B 425 -1 O LYS B 419 N TYR B 404 SHEET 4 D 9 ILE B 547 ASN B 558 -1 O ILE B 551 N HIS B 422 SHEET 5 D 9 LYS B 522 VAL B 533 -1 N ILE B 528 O THR B 552 SHEET 6 D 9 THR B 499 SER B 506 -1 N ASN B 504 O VAL B 525 SHEET 7 D 9 ARG B 478 ILE B 489 -1 N ILE B 489 O THR B 499 SHEET 8 D 9 ALA B 462 HIS B 469 -1 N ILE B 463 O SER B 484 SHEET 9 D 9 ILE B 449 ALA B 459 -1 N ASN B 451 O THR B 468 SHEET 1 E 8 GLN B 393 GLU B 398 0 SHEET 2 E 8 MET B 401 ARG B 405 -1 O VAL B 403 N VAL B 396 SHEET 3 E 8 LEU B 418 LYS B 425 -1 O LYS B 419 N TYR B 404 SHEET 4 E 8 ILE B 547 ASN B 558 -1 O ILE B 551 N HIS B 422 SHEET 5 E 8 LYS B 522 VAL B 533 -1 N ILE B 528 O THR B 552 SHEET 6 E 8 THR B 499 SER B 506 -1 N ASN B 504 O VAL B 525 SHEET 7 E 8 ARG B 478 ILE B 489 -1 N ILE B 489 O THR B 499 SHEET 8 E 8 VAL B 519 ARG B 520 1 O VAL B 519 N ASP B 479 SHEET 1 F 2 GLU B 409 GLU B 410 0 SHEET 2 F 2 ILE B 413 VAL B 414 -1 O ILE B 413 N GLU B 410 SITE 1 AC1 15 PHE A 436 ARG A 442 GLU A 446 ILE A 449 SITE 2 AC1 15 GLN A 467 VAL A 472 TRP A 473 TYR A 482 SITE 3 AC1 15 ASN A 504 ALA A 521 VAL A 525 TYR A 553 SITE 4 AC1 15 VAL A 557 TYR A 576 PHE A 579 SITE 1 AC2 11 PHE B 436 ARG B 442 GLU B 446 GLN B 467 SITE 2 AC2 11 HIS B 469 TYR B 482 ASN B 504 ILE B 523 SITE 3 AC2 11 VAL B 525 TYR B 553 TYR B 576 CRYST1 42.340 74.568 78.021 90.00 102.84 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023618 0.000000 0.005382 0.00000 SCALE2 0.000000 0.013411 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013146 0.00000